Santen to Establish Presence in Market for Back-of-the-Eye Area with VEGF Trap-Eye

Sadatoshi Furukado, Director and Executive Corporate Officer, Santen Pharmaceutical At a business briefing held on May 11, Sadatoshi Furukado, director and executive corporate officer of Santen Pharmaceutical, expressed his enthusiasm for the wet age-related macular degeneration (wet AMD) treatment VEGF...read more